PharmaShots | Incisive News in 3 Shots

Subscribe Now

KemPharm

KemPharm Signs a Definitive Agreement with Orphazyme to Acquire Arimoclomol for the Treatment of Niemann-Pick Disease Type C

KemPharm Signs a Definitive Agreement with Orphazyme to Acquire Arimoclomol for the Treatment of Niemann-Pick Disease Type C

May 16, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us